Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Apr 18;170(3):623–631. doi: 10.1007/s10549-018-4774-2

Table 2.

Personal and Clinical Social Support and Relative Odds of Noninitiation of AET (N=3,382)

% with outcome Social Support Categories
P trend
High Moderate Low

Personal social support, N 1,164 1,165 1,053
Noninitiation 21% 206 243 246
 OR, Model 1* 1.00 1.24 1.40 .002
  95% CI (1.00–1.52) (1.13–1.72)
 OR, Model 2** 1.00 1.18 1.30 .02
  95% CI (0.96–1.46) (1.05–1.62)
 OR, Model 3 1.00 1.15 1.23 .08
  95% CI (0.93–1.42) (0.98–1.55)
Clinical social support, N 1,307 1,001 1,069
Noninitiation 21% 249 203 243
 OR, Model 1* 1.00 1.12 1.31 .009
  95% CI (0.91–1.38) (1.07–1.60)
 OR, Model 2** 1.00 1.11 1.25 .03
  95% CI (0.90–1.38) (1.02–1.54)
 OR, Model 3 1.00 1.07 1.18 .12
  95% CI (0.86–1.33) (1.00–1.50)
*

Model 1: Adjusted for age (continuous), time between diagnosis and social support assessment (continuous), race (white (ref), black, Asian, Hispanic, other), and stage (I (ref), II, III)

**

Model 2: Adjusted additionally for chemotherapy (no (ref), yes), radiation (no (ref), yes), type of surgery (lumpectomy (ref), mastectomy, other), nodal status (positive, negative (ref), unknown), comorbidity at baseline (no (ref), yes, unknown), HER2 status (positive, negative (ref), unknown), educational status (high school or less, some college/vocational school (ref), college graduate, post-graduate) and income (<$25,000, $25,000–69,999, $70,000+ (ref), unknown). Further adjustment for alcohol use, physical activity, BMI, and smoking status did not substantively influence associations and these covariates were not included in models.

Model 3: Simultaneously adjusted for personal and clinical social support.